BRUKER CORPORATION Net Cash Provided by (Used in) Continuing Operations
BRUKER CORPORATION (BRKR) reported Net Cash Provided by (Used in) Continuing Operations of $15.00 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2015-05-08
- BRUKER CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2015-03-31 was $15.00M, a 1.96% decline year-over-year.
- BRUKER CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2014-12-31 was -$9.70M, a 107.35% decline year-over-year.
- BRUKER CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2014-09-30 was -$60.60M, a 208.41% decline year-over-year.
- BRUKER CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2014-06-30 was -$64.20M.
- BRUKER CORPORATION net cash provided by (used in) continuing operations for fiscal 2014 was -$119.20M, a 193.05% decline from fiscal 2013.
- BRUKER CORPORATION net cash provided by (used in) continuing operations for fiscal 2013 was $128.10M, a 98.30% increase from fiscal 2012.
- BRUKER CORPORATION net cash provided by (used in) continuing operations for fiscal 2012 was $64.60M, a 314.10% increase from fiscal 2011.
- BRUKER CORPORATION net cash provided by (used in) continuing operations for fiscal 2011 was $15.60M, a 33.05% decline from fiscal 2010.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-03-31 | $15.00M 10-Q · filed 2015-05-08 | $5.30M derived: sum of 2 quarters · filed 2015-05-08 | -$55.30M derived: sum of 3 quarters · filed 2015-05-08 | -$119.50M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$70.30M derived: sum of 2 quarters · filed 2015-02-27 | -$134.50M derived: sum of 3 quarters · filed 2015-02-27 | -$119.20M 10-K · filed 2015-02-27 |
| 2014-09-30 | -$60.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$124.80M derived: sum of 2 quarters · filed 2014-11-07 | -$109.50M 10-Q · filed 2014-11-07 | $22.40M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-06-30 | -$64.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$48.90M 10-Q · filed 2014-08-08 | $83.00M derived: sum of 3 quarters · filed 2015-05-08 | $138.90M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-03-31 | $15.30M 10-Q · filed 2015-05-08 | $147.20M derived: sum of 2 quarters · filed 2015-05-08 | $203.10M derived: sum of 3 quarters · filed 2015-05-08 | $184.60M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $131.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $187.80M derived: sum of 2 quarters · filed 2015-02-27 | $169.30M derived: sum of 3 quarters · filed 2015-02-27 | $128.10M 10-K · filed 2015-02-27 |
| 2013-09-30 | $55.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $37.40M derived: sum of 2 quarters · filed 2014-11-07 | -$3.80M 10-Q · filed 2014-11-07 | $64.70M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$18.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$59.70M 10-Q · filed 2014-08-08 | $8.80M derived: sum of 3 quarters · filed 2015-02-27 | $10.60M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$41.20M 10-Q · filed 2014-05-09 | $27.30M derived: sum of 2 quarters · filed 2015-02-27 | $29.10M derived: sum of 3 quarters · filed 2015-02-27 | $39.90M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $68.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $70.30M derived: sum of 2 quarters · filed 2015-02-27 | $81.10M derived: sum of 3 quarters · filed 2015-02-27 | $64.60M 10-K · filed 2015-02-27 |
| 2012-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $12.60M derived: sum of 2 quarters · filed 2013-11-08 | -$3.90M 10-Q · filed 2013-11-08 | $46.30M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $10.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$5.70M 10-Q · filed 2013-08-08 | $44.50M derived: sum of 3 quarters · filed 2014-02-27 | $70.50M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$16.50M 10-Q · filed 2013-05-09 | $33.70M derived: sum of 2 quarters · filed 2014-02-27 | $59.70M derived: sum of 3 quarters · filed 2014-02-27 | $36.20M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $50.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $76.20M derived: sum of 2 quarters · filed 2014-02-27 | $52.70M derived: sum of 3 quarters · filed 2014-02-27 | $15.60M 10-K · filed 2014-02-27 |
| 2011-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.50M derived: sum of 2 quarters · filed 2012-11-08 | -$34.60M 10-Q · filed 2012-11-08 | $7.80M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$23.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$60.60M 10-Q · filed 2012-08-09 | -$18.20M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2011-03-31 | -$37.10M 10-Q · filed 2012-05-09 | $5.30M derived: sum of 2 quarters · filed 2013-02-28 | ||
| 2010-12-31 | $42.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $23.30M 10-K · filed 2013-02-28 | ||
| 2010-09-30 | -$19.10M 10-Q · filed 2011-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |